7月 2026
- 首頁
- Organovo Holdings, Inc.
7月 2026Organovo Holdings, Inc.的市場佔有率分析
Conventional two dimensional (2D) cell culture models do not reflect the complexity of biological phenomena that occur in the liver microenvironment, resulting in discrepancies between in vitro predictions and in vivo realities. One of the major reasons for these differences is that primary hepatocytes, when isolated and cultured in a 2D monolayer, rapidly lose key […]
Organovo Holdings, Inc.(包含公司地區)
查看更多網站流量與參與度資訊- organovo.com
Organovo Holdings, Inc.截至 7月 2026 的總收入為 2M - 5M
Organovo Holdings, Inc. 熱門網域產生的總收入
Organovo Holdings, Inc. 熱門網域 3 年內的總收入
Organovo Holdings, Inc. 熱門網域的總收入
Organovo Holdings, Inc.的熱門網域總造訪量
了解Organovo Holdings, Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Organovo Holdings, Inc.的熱門網域平均造訪時長
分析Organovo Holdings, Inc.參與度指標。
過去 3 個月平均造訪時長
子公司細目
Organovo Holdings, Inc.的熱門網域平均頁面瀏覽量
了解Organovo Holdings, Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Organovo Holdings, Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞L’Oréal Group partnered with Organovo Inc. on Jan 1st '15.In 2015, L'Oreal partnered with 3D-bioprinting firm Organovo to figure out a way to 3D print skin tissue.
4月 4, 2025閱讀更多
新聞Organovo Holdings, Inc. attends event Annual Meeting.In a recent Annual Meeting, Organovo expanded its equity incentive plan by 1,775,000 shares, following stockholder approval.
1月 6, 2025閱讀更多
新聞Organovo Holdings, Inc. is developing novel treatment approaches in inflammatory bowel disease.SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) - Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announced that it had appointed Norman Staskey as Chief Financial Officer.
1月 6, 2025閱讀更多
查看所有Organovo Holdings, Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
